Pages that link to "Q40296974"
Jump to navigation
Jump to search
The following pages link to Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors. (Q40296974):
Displaying 50 items.
- TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu (Q21131200) (← links)
- Tumor-Induced Local and Systemic Impact on Blood Vessel Function (Q26771958) (← links)
- Cancer anti-angiogenesis vaccines: Is the tumor vasculature antigenically unique? (Q26778150) (← links)
- Combining radiotherapy with sunitinib: lessons (to be) learned (Q26800587) (← links)
- From tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumors (Q26865532) (← links)
- Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytes (Q26991991) (← links)
- Tumor endothelial cells (Q26995733) (← links)
- Control of the immune response by pro-angiogenic factors (Q27004733) (← links)
- Understanding high endothelial venules: Lessons for cancer immunology (Q27005794) (← links)
- Targeting the tumor vasculature to enhance T cell activity (Q27026329) (← links)
- Combination Approaches with Immune-Checkpoint Blockade in Cancer Therapy (Q28066199) (← links)
- Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease. (Q30469815) (← links)
- Normalization of the Vasculature for Treatment of Cancer and Other Diseases (Q30471456) (← links)
- Targeting the vasculature in hepatocellular carcinoma treatment: Starving versus normalizing blood supply. (Q33920350) (← links)
- BRAF inhibition increases tumor infiltration by T cells and enhances the antitumor activity of adoptive immunotherapy in mice (Q33996674) (← links)
- Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer (Q34031748) (← links)
- Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice (Q34245416) (← links)
- Nutritional and health benefits of pulses (Q34430806) (← links)
- Enhancement of T-cell-mediated antitumor response: angiostatic adjuvant to immunotherapy against cancer. (Q34564433) (← links)
- Combining antiangiogenic therapy with adoptive cell immunotherapy exerts better antitumor effects in non-small cell lung cancer models (Q34782683) (← links)
- Cisplatin pretreatment enhances anti-tumor activity of cytokine-induced killer cells (Q35093618) (← links)
- Enhancement of T cell recruitment and infiltration into tumours. (Q35178939) (← links)
- IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells (Q35369944) (← links)
- Axitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma model. (Q35798966) (← links)
- Tumor-targeted TNFα stabilizes tumor vessels and enhances active immunotherapy. (Q35974293) (← links)
- Dual-therapy with αvβ3-targeted Sn2 lipase-labile fumagillin-prodrug nanoparticles and zoledronic acid in the Vx2 rabbit tumor model (Q36505441) (← links)
- Pericytes on the tumor vasculature: jekyll or hyde? (Q36695062) (← links)
- Minute dosages of alpha(nu)beta3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbits (Q36804990) (← links)
- Simultaneous targeting of tumor antigens and the tumor vasculature using T lymphocyte transfer synergize to induce regression of established tumors in mice. (Q36938866) (← links)
- NF-kappa B: a new player in angiostatic therapy (Q37088045) (← links)
- Anti-angiogenesis: making the tumor vulnerable to the immune system (Q37148358) (← links)
- Peroxisome Proliferator-Activated Receptor-gamma Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in Cancer. (Q37157524) (← links)
- The roles of mast cells in anticancer immunity (Q37256987) (← links)
- Lister strain of vaccinia virus armed with endostatin-angiostatin fusion gene as a novel therapeutic agent for human pancreatic cancer (Q37389574) (← links)
- Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity (Q37398065) (← links)
- The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment (Q37516448) (← links)
- Tumor-Associated Lymphatic Vessels Upregulate PDL1 to Inhibit T-Cell Activation (Q37622038) (← links)
- The role of blood platelets in tumor angiogenesis (Q37822079) (← links)
- Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy (Q37830361) (← links)
- Persistent vascular normalization as an alternative goal of anti‐angiogenic cancer therapy (Q37852794) (← links)
- Immunological heterogeneity of the RCC microenvironment: do targeted therapies influence immune response? (Q37987862) (← links)
- Modulation of immunity by antiangiogenic molecules in cancer (Q38074154) (← links)
- Preconditioning thermal therapy: flipping the switch on IL-6 for anti-tumour immunity (Q38122205) (← links)
- Vascular remodeling in cancer. (Q38126351) (← links)
- Antiangiogenic therapy improves the antitumor effect of adoptive cell immunotherapy by normalizing tumor vasculature (Q38132055) (← links)
- Impact of MAPK Pathway Activation in BRAF(V600) Melanoma on T Cell and Dendritic Cell Function (Q38160220) (← links)
- Regulation of cytotoxic T-Lymphocyte trafficking to tumors by chemoattractants: implications for immunotherapy (Q38284345) (← links)
- Modulations in the Peripheral Immune System of Glioblastoma Patient Is Connected to Therapy and Tumor Progression-A Case Report from the IMMO-GLIO-01 Trial (Q38374300) (← links)
- Renal cell carcinoma alters endothelial receptor expression responsible for leukocyte adhesion. (Q38788951) (← links)
- Homing to solid cancers: a vascular checkpoint in adoptive cell therapy using CAR T-cells. (Q38805749) (← links)